These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15632124)

  • 1. Activation of mu-opioid receptors transfers control of Galpha subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
    J Biol Chem; 2005 Mar; 280(10):8951-60. PubMed ID: 15632124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Neuropharmacology; 2005 May; 48(6):853-68. PubMed ID: 15829256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of neural RGS-R7 and Gbeta5 Proteins in Response to Acute and Chronic Morphine.
    López-Fando A; Rodríguez-Muñoz M; Sánchez-Blázquez P; Garzón J
    Neuropsychopharmacology; 2005 Jan; 30(1):99-110. PubMed ID: 15199376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.
    Psifogeorgou K; Terzi D; Papachatzaki MM; Varidaki A; Ferguson D; Gold SJ; Zachariou V
    J Neurosci; 2011 Apr; 31(15):5617-24. PubMed ID: 21490202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macromolecular composition dictates receptor and G protein selectivity of regulator of G protein signaling (RGS) 7 and 9-2 protein complexes in living cells.
    Masuho I; Xie K; Martemyanov KA
    J Biol Chem; 2013 Aug; 288(35):25129-25142. PubMed ID: 23857581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RGSZ2 protein exists in a complex with mu-opioid receptors and regulates the desensitizing capacity of Gz proteins.
    Garzón J; Rodríguez-Muñoz M; López-Fando A; Sánchez-Blázquez P
    Neuropsychopharmacology; 2005 Sep; 30(9):1632-48. PubMed ID: 15827571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effects.
    Sánchez-Blázquez P; Rodríguez-Díaz M; López-Fando A; Rodríguez-Muñoz M; Garzón J
    Neuropharmacology; 2003 Jul; 45(1):82-95. PubMed ID: 12814661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS9 proteins facilitate acute tolerance to mu-opioid effects.
    Garzón J; Rodríguez-Díaz M; López-Fando A; Sánchez-Blázquez P
    Eur J Neurosci; 2001 Feb; 13(4):801-11. PubMed ID: 11207815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGS9-2 is a negative modulator of mu-opioid receptor function.
    Psifogeorgou K; Papakosta P; Russo SJ; Neve RL; Kardassis D; Gold SJ; Zachariou V
    J Neurochem; 2007 Oct; 103(2):617-25. PubMed ID: 17725581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous RGS protein action modulates mu-opioid signaling through Galphao. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways.
    Clark MJ; Harrison C; Zhong H; Neubig RR; Traynor JR
    J Biol Chem; 2003 Mar; 278(11):9418-25. PubMed ID: 12524446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS.
    Garzón J; Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P
    Psychopharmacology (Berl); 2005 Jun; 180(1):1-11. PubMed ID: 15830230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Wang JB; Garzón J
    Cell Signal; 2008 Oct; 20(10):1855-64. PubMed ID: 18652891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
    Clark MJ; Traynor JR
    J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity.
    Hooks SB; Waldo GL; Corbitt J; Bodor ET; Krumins AM; Harden TK
    J Biol Chem; 2003 Mar; 278(12):10087-93. PubMed ID: 12531899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.
    Gaspari S; Papachatzaki MM; Koo JW; Carr FB; Tsimpanouli ME; Stergiou E; Bagot RC; Ferguson D; Mouzon E; Chakravarty S; Deisseroth K; Lobo MK; Zachariou V
    Neuropsychopharmacology; 2014 Jul; 39(8):1968-77. PubMed ID: 24561386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; Garzón J
    Neuropharmacology; 2005 Jan; 48(1):134-50. PubMed ID: 15617734
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.